Jefferies Raises Price Target on Ceragon Networks (CRNT) to $2.50
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/19/2024
- Nasdaq, S&P tumble as Netflix, chip stocks drag; AmEx boosts Dow
- Sony/Apollo bid for Paramount could be worth as much as $29 billion - Source
- Netflix Q1 earnings top estimates on blowout subscriber growth
- Nasdaq tumbles, Treasuries dip amid earnings, geopolitical crosscurrents
- Gold prices rally past $2,400 on reports of Israel strikes on Iran
- Tritium DCFC Limited (DCFC): Three Australian subsidiaries were determined to be insolvent or likely to become insolvent
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- Jabil falls after placing CEO on paid leave amid internal investigation
- Frontier Communications (FYBR) says third party had gained unauthorized access to portions of its information technology environment
- Ibotta (IBTA) Prices 6.56M Share IPO at $88/sh
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
Pre-Open Stock Movers 11/14: (CRBP) (HAR) (DGII) (MENT) Higher; (DVAX) (HEAR) (ACM) Lower (more...)
November 14, 2016 9:24 AM ESTToday's Pre-Open Stock Movers
Dynavax Technologies (Nasdaq: DVAX) 70.7% LOWER; announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its Biologics License Application (BLA) for HEPLISAV-B [Hepatitis B Vaccine, Recombinant (Adjuvanted)] for immunization of adults 18 years and older against hepatitis B infection. The FDA issues CRLs to communicate that the Agency has completed a review cycle of an application and to request additional information for review and approval. Dynavax expects a Class 2 designation for a... More
Ceragon Networks (CRNT) Reports In-Line Q3 EPS
November 14, 2016 8:42 AM ESTCeragon Networks (NASDAQ: CRNT) reported Q3 EPS of $0.04, in-line with the analyst estimate of $0.04. Revenue for the quarter came in at $79.1 million versus the consensus estimate of $77.57 million.
For earnings history and earnings-related data on Ceragon Networks (CRNT) click here.
... MoreTrading Radar for 11/14: InterOil (IOC), Patriot National (PN), Netlist (NLST), Zoe's Kitchen (ZOES) Report
November 11, 2016 1:33 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Earnings:
AECOM Technology (NYSE: ACM) - consensus EPS $0.71
Abraxas Petroleum (Nasdaq: AXAS) - consensus loss $0.03
Akers Biosciences (Nasdaq: AKER) - no Street consensus
Aldeyra Therapeutics (Nasdaq: ALDX) - consensus loss $0.39
Amaya (NYSE: AYA) - consensus EPS $0.40
Asure Software (Nasdaq: ASUR) - consensus EPS... More
